argenx rises on ARGX-113, ARGX-110 readout

argenx S.E. (Euronext:ARGX; NASDAQ:ARGX) jumped $24.02 (79%) to $54.47 on NASDAQ Monday after reporting data on its two lead compounds, efgartigimod (ARGX-113) and ARGX-110. The biotech gained €14.20 (56%) to €39.40 on Euronext.

Of 24 myasthenia

Read the full 355 word article

User Sign In